"The controlled-release formulation extends our patent protection to 2012 and represents an opportunity to continue to expand our market potential for zileuton by offering a more convenient dosing ...
The authors evaluated the performance and robustness of controlled-release tablets made with HPMC blends of unimodal and bimodal molecular weight distribution. Table I: Commercially used grades of ...
Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...
Background and Objective: Oxycodone is a semisynthetic opioid analgesic drug classed as a strong opioid. The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for ...
The median duration of treatment was substantially longer with tapentadol ER (268 days) than with oxycodone CR (59 days), and the incidence of overall gastrointestinal treatment-emergent adverse ...
Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of ...
Indian Institute of Technology (IIT)-Hyderabad researchers have developed a method to produce controlled-release oral tablets for treating fungal infections and leishmaniasis (Kala Azar or black fever ...
Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback